Molecular and Cellular Endocrinology 406 (2015) 78–86

Contents lists available at ScienceDirect

Molecular and Cellular Endocrinology j o u r n a l h o m e p a g e : w w w. e l s e v i e r. c o m / l o c a t e / m c e

Transmembrane tumor necrosis factor-alpha sensitizes adipocytes to insulin Wenjing Zhou a,1, Peng Yang a,1, Li Liu a, Shan Zheng a, Qingling Zeng a,c, Huifang Liang a, Yazhen Zhu a, Zunyue Zhang a, Jing Wang a, Bingjiao Yin a, Feili Gong a, Yiping Wu b, Zhuoya Li a,* a

Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China Department of Plastic Surgery, Tongji Hospital, Huazhong University of Science and Technology, Wuhan 430030, China c Department of Hematology & Endocrinology, Fifth Hospital of Wuhan, Wuhan 430071, China b

A R T I C L E

I N F O

Article history: Received 10 June 2014 Received in revised form 7 February 2015 Accepted 22 February 2015 Available online 25 February 2015 Keywords: Transmembrane TNF-α Adipocyte Insulin resistance IL-6 Adiponectin

A B S T R A C T

Transmembrane TNF-α (tmTNF-α) acts both as a ligand, delivering ‘forward signaling’ via TNFR, and as a receptor, transducing ‘reverse signaling’. The contradiction of available data regarding the effect of tmTNF-α on insulin resistance may be due to imbalance in both signals. Here, we demonstrated that high glucoseinduced impairment of insulin-stimulated glucose uptake by 3T3-L1 adipocytes was concomitant with decreased tmTNF-α expression and increased soluble TNF-α (sTNF-α) secretion. However, when TACE was inhibited, preventing the conversion of tmTNF-α to sTNF-α, this insulin resistance was partially reversed, indicating a salutary role of tmTNF-α. Treatment of 3T3-L1 adipocytes with exogenous tmTNF-α promoted insulin-induced phosphorylation of IRS-1 and Akt, facilitated GLUT4 expression and membrane translocation, and increased glucose uptake while addition of sTNF-α resulted in the opposite effect. Furthermore, tmTNF-α downregulated the production of IL-6 and MCP-1 via NF-κB inactivation, as silencing of A20, an inhibitor for NF-κB, by siRNA, abolished this effect of tmTNF-α. However, tmTNF-α upregulated adiponectin expression through the PPAR-γ pathway, as inhibition of PPAR-γ by GW9662 abrogated both tmTNF-α-induced adiponectin transcription and glucose uptake. Our data suggest that tmTNF-α functions as an insulin sensitizer via forward signaling. © 2015 Elsevier Ireland Ltd. All rights reserved.

1. Introduction Transmembrane TNF-α (tmTNF-α) is a type II transmembrane protein. Its extracellular segment is cleaved by membrane-bound metalloproteases, chiefly TNF-α-converting enzyme (TACE), releasing soluble TNF-α (sTNF-α). Both forms of TNF-α exert their biological functions via binding to TNF receptors (TNFRs) (Black et al., 1997). Although sTNF-α has been widely recognized as a link between adiposity and insulin resistance, a few studies have shown that tmTNF-α is also bioactive in adipocytes and is involved in obesityrelated insulin resistance. Xu et al. demonstrated that tmTNF-α inhibits adipocyte differentiation in vitro (Xu et al., 1999), and that its expression is significantly increased in the adipose tissue in different rodent obesity models as well as in obese humans (Xu et al., 2002b). Suppressing ectodomain shedding of tmTNF-α by

* Corresponding author. Department of Immunology, Tongji Medical College, Huazhong University of Science and Technology, 13 Hangkong Road, Wuhan, Hubei 430030, China. Tel.: +86 27 83692611; fax: +86 27 83693500. E-mail address: [email protected] (Z. Li). 1 These authors contributed equally to this work. http://dx.doi.org/10.1016/j.mce.2015.02.023 0303-7207/© 2015 Elsevier Ireland Ltd. All rights reserved.

the TACE inhibitor KB-R7785 shows an antidiabetic effect (Morimoto et al., 1997). Similarly, mice heterozygous for TACE (Tace+/−) resulting in increased expression of tmTNF-α were relatively protected from obesity and insulin resistance (Serino et al., 2007). These data suggest that tmTNF-α, unlike sTNF-α, may promote insulin sensitivity. However, it has also been reported that adipocyte specific expression of noncleavable tmTNF-α impaired local insulin sensitivity and decreased whole body adipose mass in a transgenic mouse model (Xu et al., 2002a). When this noncleavable tmTNF-α mutant was expressed in multiple different organs, it led to increased weight gain and adipose tissue mass of mice fed a high-fat diet (Voros et al., 2004). The discrepancy of the reported roles of tmTNF-α in insulin sensitivity may be associated with the balance of bidirectional signaling of tmTNF-α. tmTNF-α as a ligand delivers ‘forward signaling’ via TNFR to target cell or, as a receptor, transduces ‘reverse signaling’ to its expressing cell. Since both tmTNF-α and TNFR are substrates of TACE (Scheller et al., 2011), inhibition of TACE not only increases expression of tmTNF-α and TNFR on the cell surface, but also inhibits release of these soluble molecules. tmTNF-α binds TNFR and transduces bidirectional signals simultaneously via tmTNF-α and TNFR respectively. In noncleavable tmTNF-α transgenic mice, TNFR but

W. Zhou et al./Molecular and Cellular Endocrinology 406 (2015) 78–86

not tmTNF-α can still be cleaved by TACE that is upregulated in obesity (Xu et al., 2002b). These increased soluble TNFRs bind to tmTNF-α to deliver reverse signaling, meanwhile these soluble molecules can competitively decrease interaction of tmTNF-α and cellsurface TNFRs to disrupt forward signaling. If this were the case, the beneficial effect of TACE inhibitor would be attributed to the forward signaling of tmTNF-α. Furthermore, none of those experimental systems was sufficient to distinguish the actions of tmTNF-α via forward signaling from those via reverse signaling. Obesity is considered to be a chronic low-grade inflammatory state that results in insulin resistance (Emanuela et al., 2012). Because we previously showed that exogenous tmTNF-α inhibits NF-κB activation (a pathway associated with inflammation) in the neutrophil-like cell line HL-60 (Chen et al., 2011), we hypothesized that tmTNF-α may play a role in sensitizing insulinresponse via its forward signaling. In the present study, we directly treated 3T3-L1 and human primary adipocytes with exogenous tmTNF-α and found that tmTNF-α inhibited the production of proinflammatory adipokines and promoted the release of antiinflammatory adipokine, increasing insulin sensitivity of adipocytes via forward signaling. 2. Materials and methods 2.1. Preadipocyte isolation and adipogenic differentiation Human preadipocytes were isolated from the freshly excised abdominal subcutaneous adipose tissue of seven healthy women (aged 25–42 years, with BMI of 21.8 ± 2.6 kg/m2) after liposuction or abdominoplasties at the Department of Plastic Surgery, Tongji Hospital. This study was conducted in accordance with the guidelines of the local ethics committee. Adipose tissue was minced and digested by 1 mg/ml type II collagenase (Grand Island, NY) at 37 °C for 60 min under constant shaking. After filtration through a doublelayered sterile gauze, the filtrates were centrifuged at 1000 rpm for 10 min. After lysis of erythrocytes, the cells were cultured in Dulbecco’s Modified Eagle Medium (DMEM)/F-12 with 10% FBS, 100 U/ml penicillin, 100 μg/ml streptomycin and 1% Fungizone. Once confluence of human preadipocytes was reached, adipogenic differentiation was induced for 3 days in OriCellTM Adipogenic Differentiation Medium A, and then in matched Medium B (Cyagen, Goleta, CA) for another 24 h. This was repeated 3 times. The cells were then maintained in Medium B for an additional 7–9 days until accumulated visible lipid droplets emerged. 3T3-L1 murine fibroblast cell line was grown to confluence in DMEM supplemented with 10% FBS at 37°C. Adipogenic differentiation of 3T3-L1 was induced by exposure to 0.5 mM IBMX (3-isobutyl-1-methylxanthine, Sigma-Aldrich, St. Louis, MO), 1 μM dexamethasone, and 10 μg/ml insulin for 2 days, and then to 10 μg/ml insulin alone for additional 2 days. Thereafter, the cells were maintained in the medium containing 10% FBS until >90% of the cells showing accumulated lipid vacuoles in the cytoplasm by staining with Oil Red O. 2.2. Stimulation of adipocytes with both forms of TNF-α Fully differentiated 3T3-L1 adipocytes or primary human adipocytes as target cells were treated for 24 h with 20 ng/ml sTNF-α (Peprotech, Rocky Hill, NJ) or tmTNF-α expressed at a high level by Raji cells as effector cells (Zhang et al., 2008), a malignant B-cell line had been fixed with 4% paraformaldehyde for 30 min at room temperature (RT), at an effector/target (E/T) ratio of 10:1. The untreated adipocytes served as a control. For identification of the specific actions of tmTNF-α, 4% paraformaldehyde-fixed Raji cells were treated with an anti-TNF-α antibody (BD Pharmingen, San Jose, CA) for 1 h to neutralize tmTNF-α prior to addition to the target

79

adipocytes. For glucose uptake assay or test of insulin signaling, 100 nM of insulin was added to the cells and incubated for 30 min after TNF-α-stimulation. 2.3. Glucose uptake assay 3T3-L1 adipocytes or primary human adipocytes were treated for 24 h with different concentrations of glucose and 1 μM insulin, or the two forms of TNF-α. After re-equilibration in serum- and glucose-free media for 2 h, 1 × 106 adipocytes were incubated for 30 min with or without 100 nM of insulin in glucose-free Krebs– Ringer Hepes (KRH) buffer. Glucose uptake was detected by the addition of 2-[1,2-3H]-deoxy-D-glucose (0.5 μCi/ml) for 10 min, followed by measurement of the radioactivity of the cell lysates after solubilization in 0.1 M NaOH, by a liquid scintillation counter (Perkin Elmer). Specific uptake was obtained by subtracting nonspecific deoxyglucose uptake that was determined in the presence of 20 μM cytochalasin B, from each of the resultant values (Zhou et al., 2010). 2.4. Western blot analysis Adipocytes were harvested and lysed in ice-cold lysis buffer (20 mM Tris pH 7.5, 150 mM NaCl, 1% Triton X-100) and a protease inhibitor cocktail (Sigma-Aldrich, St. Louis, MO). The total protein was obtained after centrifugation at 12,000 rpm for 20 min at 4 °C. For detection of GLUT4 translocation, 3T3-L1 adipocytes were stimulated with insulin for 30 min. The plasma membrane and cytoplasmic proteins were extracted and fractionated using the ProteoJETTM Membrane Protein Extraction kit (Fermentas, Shenzhen, China) according to the manufacturer’s recommended protocol. For determination of NF-κB p65 nuclear translocation, the cytosolic and nuclear proteins from cells were separated and isolated by NuclearCytosol Extraction Kit (Applygen Technologies Inc, Beijing, China) following the manufacturer’s instructions. Fifty micrograms of total, membranous, cytoplasmic or nuclear protein was electrophoresed on a polyarcrylamide gel and transferred to polyvinylidene difluoride membranes by electroblotting. The membranes were blocked for 2 h at RT with 5% skim milk in PBS containing 0.1% Tween-20 and then probed overnight at 4 °C with primary antibodies including anti-GLUT4 and anti-PPAR-γ (Millipore, Billerica, MA), anti-IκB-α, anti-p-Tyr-IRS-1, anti-IRS-1, antiAkt, anti-TNF-α, anti-Lamin B1, anti-caveolin-1 and anti-β-actin (Santa Cruz, CA), anti-p-Akt (Cell Signaling Technology, Beverly, MA) and anti-NF-κB p65 (Epitomics, Burlingame, CA), followed by corresponding horseradish peroxidase-conjugated anti-rabbit IgG or anti-mouse IgG secondary antibody (Pierce, Rockford, IL) at RT for 1 h. Immunoreactive bands were visualized using the enhanced chemiluminescence kit (Pierce, Rockford, IL) and the Kodak Image Station 4000 MM (East-man Kodak Co., Rochester, NY). 2.5. Flow cytometry After stimulation, 3T3-L1 adipocytes (2 × 105 cells/well) were incubated for 1 h at 4 °C with an antibody specific to murine TNF-α (Abcam, Cambridge, MA), followed by a 45 min-incubation at 4 °C with fluorescein isothiocyanate (FITC)-conjugated secondary antibody. Surface expression of tmTNF-α was analyzed on a FACS Calibur 440 E flow cytometer (Becton Dickinson, San Jose, CA). 2.6. ELISA for adipokines Commercial ELISA kits were used to detect sTNF-α, IL-6, MCP-1 (eBioscience, San Diego, CA) and adiponectin (LINCO, St. Charles, MO) in the supernatants of cultured 3T3-L1 adipocytes according to the manufacturers’ protocols.

80

W. Zhou et al./Molecular and Cellular Endocrinology 406 (2015) 78–86

Table 1 Primer sequences of mouse-specific gene for qPCR. Gene

Ref Seq ID

Reaction efficiency

Primer sequence

IL-6

NM_031168.1

95.23%

MCP-1

NM_011333.3

99.71%

Adiponectin

NM_009605.4

98.68%

A20

NM_001166402.1

96.72%

β-Actin

NM_007393.3

97.03%

Forward Reverse Forward Reverse Forward Reverse Forward Reverse Forward Reverse

2.7. Fatty acid assay The levels of free fatty acid (FFA) in the supernatant of 3T3-L1 adipocytes were detected by a Cu-colorimetric method using an ultrasensitive assay kit (Applygen, Beijing, China) according to the manufacturer’s recommended protocol. The absorbance was measured spectrophotometrically at 540 nm. 2.8. RNA interference and transfection Three siA20 oligonucleotides and a scrambled control siRNA were designed and synthesized by RiboBio (Guangzhou, China). The most efficient siA20 oligonucleotide (5′-CUUUGAAUGUGCAGCAUAA-3′ with 3′-dTdT) was chosen by screening with real-time qPCR and Western blot for A20 expression. On day 6 after induction of differentiation, 3T3-L1 adipocytes were transfected with 100 nM siRNA using LipofectamineTM 2000 (Invitrogen, Eugene, OR) reagent according to the manufacturer’s instructions. At 48 h after transfection, the cells were treated for 24 h with the two forms of TNF-α, and then harvested for RNA or protein extraction.

AGTTGCCTTCTTGGGACTGA CAGAATTGCCATTGCACAAC CCACTCACCTGCTGCTACTCAT TGGTGATCCTCTTGTAGCTCTCC TGTTCCTCTTAATCCTGCCCA CCAACCTGCACAAGTTCCCT GACCAAGTTGTCCCATTC TTCCTCAGGCTTTGTATTT CATCCGTAAAGACCTCTATGCCAAC ATGGAGCCACCGATCCACA

adipocytes in the presence of 15 mM glucose, 25 mM glucose markedly decreased the response of adipocytes to insulin with a significant reduction of IRS-1 expression (Fig. 1A). Meanwhile tmTNF-α expressed by adipocytes was almost completely proteolytically processed into sTNF-α in the presence of 25 mM glucose. In contrast, in the presence of 15 mM glucose 3T3-L1 adipocytes expressed tmTNF-α at high level but secreted sTNF-α at basal level (Fig. 1B and D). Although total 26 kD tmTNF-α production in cell lysate was stimulated by both 15 mM and 25 mM glucose (Fig. 1C), the evidence that only elevated release of sTNF-α from adipocytes was observed in 25 mM glucose (Fig. 1D) strongly indicated an obvious activation of TACE in this condition. When we used a specific antibody to neutralize TACE, a proteinase responsible for the cleavage of tmTNF-α into sTNF-α, 25 mM glucose-induced proteolytic processing of tmTNF-α was significantly suppressed, resulting in increased tmTNF-α expression and decreased sTNF-α release (Fig. 1E and F). The high glucose-induced insulin resistance could be partially reversed by TACE antibody, as manifested by the enhancement of cellular glucose uptake in response to insulin (Fig. 1G). These results point out a different action between tmTNF-α and sTNF-α in insulin resistance.

2.9. Real-time quantitative PCR analysis Total RNA was extracted from 3T3-L1 adipocytes using TRIzol reagents (Invitrogen). Two micrograms of the total RNA was reversely transcribed into first-strand cDNA using the TransScript FirstStrand cDNA Synthesis SuperMix (TransGen, Beijing, China). cDNA was amplified with gene-specific forward and reverse primers (Table 1) in a volume of 20 μl UltraSYBR Mixture (with ROX) (Cowin Biotech, Beijing, China) using an Mx3000P Real-Time PCR System (Stratagene). The reactions were performed in triplicate for 5 min at 95 °C, followed by 15 s at 95 °C, 20 s at 58 °C and 20 s at 72 °C for 40 cycles. Results were analyzed with Stratagene Mx3000 software using the 2−ΔΔCt method and normalized with β-actin. 2.10. Statistics Statistical analyses were performed by one-way or two-way ANOVA. Data are presented as mean ± SD. Differences with P values

Transmembrane tumor necrosis factor-alpha sensitizes adipocytes to insulin.

Transmembrane TNF-α (tmTNF-α) acts both as a ligand, delivering 'forward signaling' via TNFR, and as a receptor, transducing 'reverse signaling'. The ...
2MB Sizes 1 Downloads 5 Views

Recommend Documents


Novel strategies to mimic transmembrane tumor necrosis factor-dependent activation of tumor necrosis factor receptor 2.
Tumor necrosis factor receptor 2 (TNFR2) is known to mediate immune suppression and tissue regeneration. Interestingly, the transmembrane form of tumor necrosis factor (tmTNF) is necessary to robustly activate TNFR2. To characterize the stoichiometry

The mechanisms of carnosic acid attenuates tumor necrosis factor-α-mediated inflammation and insulin resistance in 3T3-L1 adipocytes.
Insulin resistance has been linked to a low-grade chronic inflammatory response. Carnosic acid (CA), which is found in rosemary, has been reported to have antioxidant, anti-inflammation, and anti-adipogenic properties. Here, we examined the effects o

Phillyrin, a natural lignan, attenuates tumor necrosis factor α-mediated insulin resistance and lipolytic acceleration in 3T3-L1 adipocytes.
In obese adipose tissue, tumor necrosis factor-α secreted from macrophages plays an important role in the adipocyte dysfunctions, including insulin resistance, lipolytic acceleration, and changes of adipokines, which promote the development of obesit

Tumor necrosis factor-α sensitizes breast cancer cells to natural products with proteasome-inhibitory activity leading to apoptosis.
The inflammatory microenvironment plays an important role in the process of tumor development. Tumor necrosis factor-α (TNF-α), a key pro-inflammatory cytokine, has a significant role in this process. Natural medicinal products such as Withaferin A (

PTPN2 Loss Sensitizes Tumor Cells to Immunotherapy.
Ptpn2 loss increases tumor cell IFNγ signaling to enhance antigen presentation and antitumor immunity.

Selective insulin resistance in adipocytes.
Aside from glucose metabolism, insulin regulates a variety of pathways in peripheral tissues. Under insulin-resistant conditions, it is well known that insulin-stimulated glucose uptake is impaired, and many studies attribute this to a defect in Akt

Parthenolide Sensitizes Human Colorectal Cancer Cells to Tumor Necrosis Factor-related Apoptosis-inducing Ligand through Mitochondrial and Caspase Dependent Pathway.
Combination therapy utilizing tumor necrosis factor (TNF)-related apoptosis-inducing ligand (TRAIL) in conjunction with other anticancer agents, is a promising strategy to overcome TRAIL resistance in malignant cells. Recently, parthenolide (PT) has

Tumor necrosis factor, tumor necrosis factor inhibition, and cancer risk.
Tumor necrosis factor (TNF) is a highly pleiotropic cytokine with multiple activities other than its originally discovered role of tumor necrosis in rodents. TNF is now understood to play a contextual role in driving either tumor elimination or promo

Insulin receptor activation with transmembrane domain ligands.
Complementary surfaces are buried when peptide hormones, growth factors, or cytokines bind and activate cellular receptors. Although these extended surfaces provide high affinity and specificity to the interactions, they also present great challenges

Rosmarinic acid suppresses adipogenesis, lipolysis in 3T3-L1 adipocytes, lipopolysaccharide-stimulated tumor necrosis factor-α secretion in macrophages, and inflammatory mediators in 3T3-L1 adipocytes.
Background: Rosmarinic acid (RA) is a natural phenol carboxylic acid with many promising biological effects. It may be a suitable candidate for improving obesity-related adipose tissue dysfunction. Objective: We aimed to investigate the therapeutic u